Company Analysis

Cvs Health Corporation (CVS)

NYSE: CVS · Retail-Drug Stores and Proprietary Stores · Woonsocket, RI · filing with the SEC since 1994
Grade5.6
◀ Past 5.5● Present 6.0▶ Future 5.1

Who owns Cvs Health Corporation

As filed with the SEC
Holders of 5% or more
3
Blackrock, Inc. holds 8.3% of Common Stock, as its SCHEDULE 13G/A filed Jul 16, 2025 says.
Directors and officers
22
report now, of 57 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 16, 2025 · Common Stock · 7.1% in Apr 17, 2025
8.3%
Vanguard Capital Management
7.51%
Capital World Investors
5.5%
Dodge & Cox
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock · reported falling below 5%
under 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%
under 5%
What CVS reports owning in othersstakes of 5% or more, and other ties

453 subsidiaries in 7 countries, from the list filed with the 10-K filed Feb 10, 2026. Its Form 13F-HR for Jun 30, 2026 lists 21 holdings. The record carries no value for them.

Insider tradesForm 4
8sales
1purchases
0sales on a scheduled plan
2people selling
$324Msold, in dollars
$2.0Mbought, in dollars
Open-market trades on Form 4 from Nov 6, 2025 to Nov 6, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
17181920212223242526
2026 runs to Nov 6, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 57 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Robbins Larrydirector7$318M00$0
Mandadi TilakEVP, Chief Exp & Tech Officer1$6.2M00$0
Shah Prem SEVP and Group President0$001$2.0M
SI Assistanton CVS · research, not advice